Dr. Alex Ashenden is a research scientist at SA Pathology, employed since 2023 as a part of the MRFF-funded NewbornsInSA research project, where his research focuses on metabolomic and lipidomic analysis via LC-MS. His honours and PhD were completed at Flinders University between 2017 and 2022, where he initially studied the interactions between nanoparticles and lipid membrane models, before focusing further on the stability and function of the models themselves.
Dr. Alex Ashenden is a research scientist at SA Pathology, employed since 2023 as a part of the MRFF-funded NewbornsInSA research project, where his research focuses on metabolomic and lipidomic analysis via LC-MS. His honours and PhD were completed at Flinders University between 2017 and 2022, where he initially studied the interactions between nanoparticles and lipid membrane models, before focusing further on the stability and function of the models themselves.